PCSK9 and systemic inflammatory response syndrome: Patients with Gram-negative and Gram-positive infections in the non-COVID-19 SIRS/sepsis group exhibited comparable plasma PCSK9 levels to those without any discernible pathogen in their bloodstream [53] (Fig. 5).